Table 1.

FDA-approved doses for on-label indications and dosage ranges studied in randomized clinical trials in off-label settings

FDA-approved doses for on-label indications and dosage ranges studied in randomized clinical trials in off-label settings

GI indicates gastrointestinal.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal